Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-30 · accession 0001599298-25-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-02 | 2025-05-30 | SMMT | DUGGAN ROBERT W | Co-CEO, Dir, 10% | M - OptEx | $2.64 | +74.5K | 555.75M | +0.0% | +$196.8K |
| D | 2025-06-02 | 2025-05-30 | SMMT | DUGGAN ROBERT W | Co-CEO, Dir, 10% | M - OptEx | $0.00 | -74.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | M | A | 74,545 | $2.64 | 555,754,696 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-05-30 | M | D | 74,545 | $0.00 | 0 | D | $2.64 · — to 2034-01-02 | 74,545 Common Stock | (F3) The option was granted on January 2, 2024. The shares underlying the option vested in four equal quarterly installments on March 31, June 30, September 30 and December 31, 2024. |